bicycle therapeutics Logo (WIPO, 11/26/2021)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark bicycle therapeutics was filed as Figurative mark on 11/26/2021 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Letters or numerals forming geometrical figures, written or typographical matter in perspective #Letters presenting a special form of writing #Colours #Two predominant colours
| Trademark form | Figurative mark |
| File reference | 1688031 |
| Register number | UK00003657018 |
| Countries | 
|
| Base trademark |
No. UK00003657018,
October 29, 2021
|
| Application date | November 26, 2021 |
| Expiration date | November 26, 2031 |
Trademark owner
Building 900,
Babraham Research Campus,
GB
Babraham Research Campus,
GB
Trademark representatives
Lacon London,
84 Theobalds Road,
GB
goods and services
05
Pharmaceuticals; pharmaceutical preparations; pharmaceutical
products; pharmaceutical products and preparations for use
in relation to oncology; pharmaceutical products and
preparations for use in relation to ophthalmology;
pharmaceutical products and preparations for use in relation
to neurology; anti-infective pharmaceutical products and
preparations; pharmaceutical products and preparations for
the treatment and/or prevention of respiratory disease;
pharmaceutical products and preparations for the treatment
and/or prevention of cardiovascular disease; pharmaceutical
products and preparations for the treatment and/or
prevention of metabolic disease; pharmaceutical products and
preparations for the treatment and/or prevention of viral
infections; pharmaceutical products and preparations for use
in diagnostics and imaging; pharmaceutical products and
preparations for the treatment and/or prevention of renal
disease; pharmaceutical products and preparations for the
treatment and/or prevention of gastrointestinal disease;
pharmaceutical products and preparations for the treatment
and/or prevention of muscular skeletal disease
42
Scientific and technological services and research and
design relating thereto; industrial analysis and research
services; pharmaceutical research and development services;
medical research and development services; pharmaceutical
testing and clinical trials; clinical trials; research and
development in the field of oncology; research and
development in the field of ophthalmology; research and
development in the field of neurology; research and
development in the field of anti-infective pharmaceuticals;
research and development in the field of respiratory
disease; research and development in the field of
cardiovascular disease; research and development in the
field of metabolic disease; research and development in the
field of antiviral drugs; research and development in the
field of diagnostics and imaging; research and development
in the field of renal disease; research and development in
the field of gastrointestinal disease; research and
development in the field of muscular skeletal disease;
information consultancy and advisory services relating to
the aforesaid
44
Medical services; healthcare services; pharmaceutical
services; medical consulting services; advisory services
relating to pharmaceuticals; consultancy and information
services relating to pharmaceuticals; medical services in
the field of oncology; medical services in the field of
ophthalmology; medical services in the field of neurology;
medical services in the field of anti-infectives; medical
services in connection with respiratory disease; medical
services in connection with cardiovascular disease; medical
services in connection with metabolic disease; medical
services in connection with the treatment and/or prevention
of viral infections; medical services in connection with
diagnostics and imaging; medical services in connection with
renal disease; medical services in connection with
gastrointestinal disease; medical services in connection
with muscular skeletal disease; pharmaceutical services in
the field of oncology; pharmaceutical services in the field
of ophthalmology; pharmaceutical services in the field of
neurology; pharmaceutical services in the field of
anti-infectives; pharmaceutical services in connection with
respiratory disease; pharmaceutical services in connection
with cardiovascular disease; pharmaceutical services in
connection with metabolic disease; pharmaceutical services
in connection with the treatment and/or prevention of viral
infections; pharmaceutical services in connection with
diagnostics and imaging; pharmaceutical services in
connection with renal disease; pharmaceutical services in
connection with gastrointestinal disease; pharmaceutical
services in connection with muscular skeletal disease;
information, consultancy and advisory services relating to
the aforesaid; medical testing
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 20, 2023 | 2023/29 Gaz | JP | Rejection |
| March 1, 2023 | 2023/9 Gaz | EM | Rejection |
| December 23, 2022 | 2022/52 Gaz | US | Rejection |
| November 26, 2021 | 2022/38 Gaz | GB | Registration |
ID: 141688031